Algorae Pharmaceuticals (STU:LHI0) Change In Other Working Capital : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Algorae Pharmaceuticals Change In Other Working Capital?

Algorae Pharmaceuticals's Change In Other Working Capital for the quarter that ended in Dec. 2023 was €0.00 Mil. It means Algorae Pharmaceuticals's Other Working Capital stayed the same from Jun. 2023 to Dec. 2023 .

Algorae Pharmaceuticals's Change In Other Working Capital for the fiscal year that ended in Jun. 2023 was €0.00 Mil. It means Algorae Pharmaceuticals's Other Working Capital stayed the same from Jun. 2022 to Jun. 2023 .

Algorae Pharmaceuticals Change In Other Working Capital Historical Data

The historical data trend for Algorae Pharmaceuticals's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algorae Pharmaceuticals Change In Other Working Capital Chart

Algorae Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Other Working Capital

Get a 7-Day Free Trial

Algorae Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Other Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

Algorae Pharmaceuticals Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Algorae Pharmaceuticals Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Algorae Pharmaceuticals's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Algorae Pharmaceuticals (STU:LHI0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algorae Pharmaceuticals Ltd (STU:LHI0) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

LVCLY:USA LVCLF:USA 1AI:Australia

Address

201 Sussex Street, Level 16, Tower 2, Darling Park, Sydney, NSW, AUS, 2000

Website

https://www.algoraepharma.com

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer's disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.

Algorae Pharmaceuticals (STU:LHI0) Headlines

No Headlines